publication venue for Efficacy and Safety of Second‐Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID. 14:e70203. 2026 TNF Inhibitor‐Induced Sarcoidosis‐Like Lesions in Inflammatory Bowel Disease. 14:e70015. 2026
